{
    "eid": "2-s2.0-85122571336",
    "title": "Comparison of efficacies of full and abbreviated cascade impactors in aerosol characterization of nebulized salbutamol sulfate produced by a jet nebulizer",
    "cover-date": "2021-01-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Pharmacy",
            "@code": "3611",
            "@abbrev": "HEAL"
        },
        {
            "@_fa": "true",
            "$": "Pharmaceutical Science",
            "@code": "3003",
            "@abbrev": "PHAR"
        },
        {
            "@_fa": "true",
            "$": "Pharmacology (medical)",
            "@code": "2736",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "Aerosol characterization",
        "Fine particle dose (FPD)",
        "Fine particle fraction (FPF)",
        "Impactor",
        "Salbutamol sulfate"
    ],
    "authors": [
        "Nattika Nimmano",
        "Safura Binti Mohd Mohari"
    ],
    "citedby-count": 1,
    "ref-count": 22,
    "ref-list": [
        "Aerosolization performance of jet nebulizers and biopharmaceutical aspects",
        "Mannitol delivery by vibrating mesh nebulisation for enhancing mucociliary clearance",
        "A novel aerodynamic sizing method for pharmaceutical aerosols using image-based analysis of settling velocities",
        "Evaluation of an abbreviated impactor for fine particle fraction (FPF) determination of metered dose inhalers (MDI)",
        "Assessment of a breathless patient",
        "Fine particle profile of fluticasone propionate/formoterol fumarate versus other combination products: the DIFFUSE study",
        "A sampling and dilution system for droplet aerosols from medical nebulisers developed for use with an optical particle counter",
        "Next Generation Pharmaceutical Impactor (A new impactor for pharmaceutical inhaler testing). Part I: Design",
        "Next generation pharmaceutical impactor (a new impactor for pharmaceutical inhaler testing)",
        "Cascade impactors for the size characterization of aerosols from medical inhalers: their uses and limitations",
        "Relative precision of inhaler aerodynamic particle size distribution (APSD) metrics by full resolution and abbreviated andersen cascade impactors (ACIs): Part 1",
        "The abbreviated impactor measurement (AIM) concept: part 1\u2013Influence of particle bounce and reentrainment-evaluation with a \u201cdry\u201d pressurized metered dose inhaler (pMDI)-based formulation",
        "The abbreviated impactor measurement (AIM) concept: part II\u2013Influence of evaporation of a volatile component-evaluation with a \u201cdroplet-producing\u201d pressurized metered dose inhaler (pMDI)-based formulation containing ethanol as cosolvent",
        "Evaluation of abbreviated impactor measurements (AIM) and efficient data analysis (EDA) for dry powder inhalers (DPIs) against the full-resolution next generation impactor (NGI)",
        "Good cascade impactor practice (GCIP) and considerations for \u201cin-use\u201d specifications",
        "Aerosol characterisation of nebulised liposomes co-loaded with erlotinib and genistein using an abbreviated cascade impactor method",
        "In vitro effect of different airflow rates on the aerosol properties of nebulized glycopyrrolate in the eFlow\u00ae closed system and tiotropium delivered in the HandiHaler\u00ae",
        "A methodology to study impactor particle reentrainment and a proposed stage coating for the NGI",
        "Measurement of aerodynamic particle size distribution of orally inhaled products by cascade impactor: how to let the product specification drive the quality requirements of the cascade Impactor",
        "Improved quality control metrics for cascade impaction measurements of orally inhaled drug products (OIPs)",
        "Assessment of abbreviated impactor measurement (AIM) methods for nebulizer characterization",
        "Comparison of two approaches for treating cascade impaction mass balance measurements"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "London",
            "@id": "60016379",
            "affilname": "UCL School of Pharmacy",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60016379",
            "affiliation-country": "United Kingdom"
        }
    ],
    "funding": []
}